Advertisement MM2 Group closes $1.1 million sales contract - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

MM2 Group closes $1.1 million sales contract

MM2 Group has reported that its wholly-owned subsidiary, Genotec Nutritionals has closed on a very large order for high potency odorless fish oil softgels. The transaction is valued at over $1.1 million, which is to be delivered over the next 7 months.

The company says fish oil is rich in unsaturated fatty acids and provides essential Omega-3 fatty acids (EPA and DHA) that help prevent menopausal symptoms, promotes better circulation and neural development, and lowers cholesterol and triglycerides.

Mark Meller, CEO of MM2 Group, said, “This order is among the largest in the company’s history, and rapidly accelerates our growth plan. We have successfully positioned Genotec to grow into a very large company in the near future.”